Literature DB >> 31524279

Linc01105 acts as an oncogene in the development of neuroblastoma.

Mujie Ye1, Jing Ma2, Baihui Liu1, Xiangqi Liu1, Duan Ma2, Kuiran Dong1.   

Abstract

Previous research from our group revealed that the long coding RNA (lncRNA) linc01105 is associated with neuroblastoma proliferation and apoptosis, and that its expression is correlated with the International Neuroblastoma Staging System stage. The purpose of the present study was to investigate the functions of Linc01105 in neuroblastoma. Lentivirus‑mediated linc01105 knockdown was performed in the neuroblastoma cell line SH‑SY5Y. The expression levels of linc01105 and of other associated genes were measured by reverse transcription‑quantitative PCR. Cell Counting Kit‑8 assay and flow cytometry were used to determine cell viability and apoptosis. The levels of proteins were detected using western blot analysis. Bioinformatics analysis and luciferase reporter assays were used to examine the relationship between linc01105, miR‑6769b‑5p and vascular endothelial growth factor A (VEGFA). Angiogenesis ability was measured using a tube formation assay. The results demonstrated that HIF‑1α overexpression promoted the transcription of linc01105 by acting as a transcription factor. Knockdown of linc01105 inhibited neuroblastoma cell proliferation, migration and invasion, and it induced apoptosis. In addition, linc01105 affected the expression of p53 and Bcl‑2 family proteins and activated the caspase signaling pathway. Further functional experiments revealed that linc01105 promoted the expression of the miR‑6769b‑5p target gene VEGFA by acting as a sponge of miR‑6769b‑5p. In conclusion, linc01105 may contribute to neuroblastoma tumorigenesis and development. The present findings indicated that the interplay between the p53/caspase pathway and the linc01105/miR‑6769b‑5p/VEGFA axis may have important roles in the development of neuroblastoma.

Entities:  

Year:  2019        PMID: 31524279     DOI: 10.3892/or.2019.7257

Source DB:  PubMed          Journal:  Oncol Rep        ISSN: 1021-335X            Impact factor:   3.906


  6 in total

1.  Joint analysis of lncRNA m6A methylome and lncRNA/mRNA expression profiles in gastric cancer.

Authors:  Zhi Lv; Liping Sun; Qian Xu; Chengzhong Xing; Yuan Yuan
Journal:  Cancer Cell Int       Date:  2020-09-25       Impact factor: 5.722

2.  Long non-coding RNA profiling of pediatric Medulloblastoma.

Authors:  Varun Kesherwani; Mamta Shukla; Don W Coulter; J Graham Sharp; Shantaram S Joshi; Nagendra K Chaturvedi
Journal:  BMC Med Genomics       Date:  2020-06-26       Impact factor: 3.063

3.  Downregulation of MEG3 promotes neuroblastoma development through FOXO1-mediated autophagy and mTOR-mediated epithelial-mesenchymal transition.

Authors:  Mujie Ye; Hong Lu; Weitao Tang; Tianrui Jing; Shiyu Chen; Meng Wei; Jingjing Zhang; Jing Wang; Jing Ma; Duan Ma; Kuiran Dong
Journal:  Int J Biol Sci       Date:  2020-10-03       Impact factor: 6.580

4.  Downregulation of MEG3 and upregulation of EZH2 cooperatively promote neuroblastoma progression.

Authors:  Mujie Ye; Runnan Gao; Shiyu Chen; Meng Wei; Jing Wang; Bowen Zhang; Suwen Wu; Yuexin Xu; Peixuan Wu; Xin Chen; Jing Ma; Duan Ma; Kuiran Dong
Journal:  J Cell Mol Med       Date:  2022-03-08       Impact factor: 5.310

5.  SP1-Mediated Upregulation of Long Noncoding RNA ZFAS1 Involved in Non-syndromic Cleft Lip and Palate via Inactivating WNT/β-Catenin Signaling Pathway.

Authors:  Shiyu Chen; Zhonglin Jia; Ming Cai; Mujie Ye; Dandan Wu; Teng Wan; Bowen Zhang; Peixuan Wu; Yuexin Xu; Yuntao Guo; Chan Tian; Duan Ma; Jing Ma
Journal:  Front Cell Dev Biol       Date:  2021-06-29

6.  LINC00839 Regulates Proliferation, Migration, Invasion, Apoptosis and Glycolysis in Neuroblastoma Cells Through miR-338-3p/GLUT1 Axis.

Authors:  Lixia Yang; Liangyan Pei; Jilong Yi
Journal:  Neuropsychiatr Dis Treat       Date:  2021-06-21       Impact factor: 2.570

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.